HOME >> BIOLOGY >> NEWS
Thyroid cancer discovery points to new treatments, prevention

KINGSTON, Ont. -- The actions of a mutated protein in cells linked to thyroid cancer have been uncovered by researchers at Queen's University. The discovery paves the way for the future development of drugs to more effectively target, treat and possibly even prevent both inherited and non-inherited thyroid cancers.

"We now know why this gene causes these tumours and can start looking at how best to target the mutant proteins so that the cells expressing them can be killed or stopped from growing," says Lois Mulligan, professor of pathology and molecular medicine with the Division of Cancer Biology and Genetics of the Queen's Cancer Research Institute. She is senior author of a study to be published November 15 in the journal Cancer Research.

Taranjit S. Gujral, a Ph D student in Queen's Department of Pathology and Molecular Medicine and lead author on the paper, developed three-dimensional models of the mutated RET protein implicated in a condition causing cancerous thyroid tumours. The model allowed him to predict and compare the protein's molecular actions and to see that the protein was ten times more active than normal in cells associated with Multiple Endocrine Neoplasia 2B (MEN 2B) syndrome, an inherited cancer syndrome. Co-authors on the study include Vinay K. Singh and Zongchao Jia of Queen's Biochemistry Department.

"It's like stepping on the gas in a car and getting way more gas than you bargained for," says Mulligan. "The mutation may cause some new actions but it chiefly does some actions more efficiently than normal."

MEN 2B is a dominantly inherited condition the most severe of its kind and is characterized by the early onset of thyroid tumours, sometimes even affecting infants, and can also cause developmental abnormalities including elongated bones, gastric problems and bumpy lips.

MEN 2B is currently treated with surgery, and other treatments, such as radiation and chemotherapy are not very eff
'"/>

Contact: Sarah Withrow
withrows@post.queensu.ca
613-533-3280
Queen's University
15-Nov-2006


Page: 1 2

Related biology news :

1. Thyroid hormone, brain development, and behavior
2. Thyroid treatment can trigger homeland security detectors
3. Protein chatter linked to cancer activation
4. Newly created cancer stem cells could aid breast cancer research
5. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
6. ESF EURYI award winner aims to stop cancer cells reading their own DNA
7. No evidence that widely prescribed statins protect against prostate cancer
8. A study by the MUHC and McGill University opens a new door to understanding cancer
9. New study suggests Concord grape juice may provide protection against breast cancer
10. New test improves detection of liver cancer
11. High-intensity ultrasound may launch attack on cancer, wherever it lurks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: